e-learning
resources
Munich 2014
Monday, 08.09.2014
The story continues: impact of OSA on cardiometabolic parameters
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Hemodynamic effects of Cheyne-Stokes respiration in heart failure?
O. Oldenburg, H. Fox, J. Spießhöfer, T. Bitter, D. Horstkotte (Bad Oeynhausen, Germany)
Source:
International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Session:
The story continues: impact of OSA on cardiometabolic parameters
Session type:
Poster Discussion
Number:
1753
Disease area:
Pulmonary vascular diseases
Abstract
Cheyne-Stokes respiration (CSR) in heart failure (HF) patients is characterized by hyperventilation (HV) with low arterial partial pressure of CO₂ (pCO₂). It is still questioned whether this HL characterizes a compensatory response to HF or represents an independent comorbidity. Aim of the present study was to investigate the hemodynamic effects of HL.Hemodynamic effects of voluntary HV were investigated in 15 healthy volunteers (HVOL; 13 male, 25±4 years, BNP<49pg/ml, NYHA O, LVEF > 55%) and 19 HF patients (14male, 67±12years, NYHA class 2.6±0.6, BNP 802±839pg/ml, LV-EF 33.5 ±9.0%). Non-invasive hemodynamic monitoring was used in HVOL whereas invasive measurements were used in HF patients. Transcutaneous (tc) pCO₂ was used in HVOL and aortal blood gas analysis was used in HF patients to verify and quantify HV.During HV PtcCO₂ in HVOL dropped from 38.74±2.5 to 28.6±3.3 mmHg (p<0.001) and pCO₂ in HF patients from 33.0 ± 3.6 to 22.3 ± 3.3mmHg (p<0.001). There was a significant increase in cardiac output (CO) in HVOL and HF, mainly based on an increase in heart rate (HR).
Healthy Volunteers
Heart Failure Patients
CO, l/min
6.2±1.3
7.5±1.3
p<0.001
4.3±1.3
5.0±1.4
p=0.004
SV, ml
93.7±19.6
93.8±21.4
n.s.
60.8±28.0
67.4±23.4
n.s.
HR, bpm
67.4±7.6
82.8±10.9
p<0.001
77.8±18.0
86.1±22.8
p=0001
HV leads to an increase in cardiac output in healthy volunteers as well as in heart failure patients. This increase is mainly due to an increase in heart rate. Cheyne-Stokes respiration with associated hyperventilation might be a compensatory mechanism in patients with a failing heart, but because this is due to an increase in heart rate, it might be deleterious in the long run.
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Oldenburg, H. Fox, J. Spießhöfer, T. Bitter, D. Horstkotte (Bad Oeynhausen, Germany). Hemodynamic effects of Cheyne-Stokes respiration in heart failure?. Eur Respir J 2014; 44: Suppl. 58, 1753
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
PERIPHERAL ARTERIAL TONOMETRY AND INTIMA MEDIA THICKNESS IN OBSTRUCTIVE SLEEP APNEA.
Related content which might interest you:
Varying patterns of hyperpnea during Cheyne-Stokes respiration in heart failure: Implication for cardiac function
Source: International Congress 2016 – Central sleep apnoea and the central regulation of obstructive and central sleep apneoa
Year: 2016
Prevalence and course of sleep-disordered breathing in acute decompensated heart failure
Source: International Congress 2014 – Sleep disordered breathing 5
Year: 2014
Sleep quality and duration in patients with chronic heart failure and sleep disordered breathing
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014
Day-night pattern of defibrillator shocks in patients with chronic heart failure: The impact of Cheyne-Stokes respiration and obstructive sleep apnoea
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013
Prediction of therapeutic effectiveness of nocturnal oxygen supplementation in Cheyne-Stokes breathing
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014
Effects of pathological respiratory pattern on heart rate turbulence in sleep apnea
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
Implications of revised rules on scoring apneic and hypopneic respiratory events in heart failure patients with nocturnal Cheyne-Stokes respiration
Source: Annual Congress 2013 –Ask, see and do: old and new technology in sleep disordered breathing
Year: 2013
Evaluation of the apnea-hypopnea index determined by adaptive-servo ventilation devices in heart failure patients with sleep disordered breathing
Source: International Congress 2014 – The technical and diagnostic agenda in OSA
Year: 2014
Influence of adaptive servoventilation therapy on autonomic function and baroreceptor reflex sensitivity in heart failure patients with Cheyne-Stokes respiration compared to healthy volunteers
Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing
Year: 2014
Atrial dysrhythmia control through cardioversion improves sleep disordered breathing in patients with heart failure
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
Daytime oxygen delivery predicts its success during nocturnal supplementation in Cheyne-Stokes breathing
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014
Validation of a Cheyne-Stokes respiration (CSR) detection algorithm for a CPAP device
Source: International Congress 2014 – The technical and diagnostic agenda in OSA
Year: 2014
Eye diseases in sleep related breathing disorders
Source: International Congress 2014 – Sleep disordered breathing 5
Year: 2014
HFNC: A new therapeutic approach in patients with chronic heart failure and Cheyne-Stokes breathing
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016
Analysis of circadian blood pressure rhythms and cardiovascular risk factors in patients with hypertension and sleep apnea syndrome
Source: International Congress 2014 – Sleep disordered breathing 5
Year: 2014
Response to exercise in patients with obstructive sleep apnea
Source: International Congress 2014 – Sleep disordered breathing 5
Year: 2014
Night to night variability in sleep breathing pattern in people awaiting biventricular pacemaker for severe heart failure
Source: International Congress 2014 – Sleep disordered breathing 5
Year: 2014
Obstructive sleep apnoea syndrome and a calculation of cardiovascular risk
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
Microalbuminuria in obstrucive sleep apnea syndrome
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
LATE-BREAKING ABSTRACT: The influence of CPAP-therapy on system inflamation activity in patients with obstructive sleep apnea
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept